UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Telos Capital Management Inc.

Telos Capital Management Inc. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,601 shares of the healthcare conglomerate’s stock after buying an additional 265 shares during the quarter. Telos Capital Management Inc.’s holdings in UnitedHealth Group were worth $843,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Moneta Group Investment Advisors LLC grew its holdings in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $5,210,004,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of UnitedHealth Group by 143.4% during the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after purchasing an additional 2,058,829 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on UNH shares. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Barclays increased their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday. Morgan Stanley decreased their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. TD Cowen decreased their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Three investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $569.68.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $478.99 on Thursday. The stock has a fifty day moving average of $489.51 and a 200-day moving average of $515.38. The company has a market capitalization of $441.60 billion, a PE ratio of 29.28, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 earnings per share. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.75 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.